To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer Under MSS/pMMR

NCT07738042 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Interventions

DRUG: Sintilimab
DRUG: CAPOX (oxaliplatin/capecitabine)
RADIATION: Short-course radiotherapy
BIOLOGICAL: Intestinal bacteria transplantation

Sponsor

Tianjin Medical University Cancer Institute and Hospital